Methyl imidazo[1,2-a]pyridine-8-carboxylate

Catalog No. :
ACJOAZ725
CAS No. :
133427-07-3
Molecular Formula :
C9H8N2O2
Molecular Weight :
176.18

IUPAC Name:methyl imidazo[1,2-a]pyridine-8-carboxylate

Methyl imidazo[1,2-a]pyridine-8-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25g98%$143.00Login to see priceIn stockInquiry
100g98%$516.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl imidazo[1,2-a]pyridine-8-carboxylate
IUPAC Namemethyl imidazo[1,2-a]pyridine-8-carboxylate
MDL No.MFCD09842621
Molecular FormulaC9H8N2O2
Molecular Weight176.18
SMILESCOC(=O)C1=CC=CN2C=CN=C12
InChI KeyUJLRMEAGEVCFNJ-UHFFFAOYSA-N
SynonymMethyl Imidazo[1,2-a]pyridine-8-carboxylate | 133427-07-3 | IMIDAZO[1,2-A]PYRIDINE-8-CARBOXYLIC ACID METHYL ESTER | MFCD09842621 | Imidazo[1,2-a]pyridine-8-carboxylic acid methyl ester hydrochloride | Methylimidazo[1,2-a]pyridine-8-carboxylate | SCHEMBL1878367 | DTXSID
CAS No.133427-07-3
PubChem CID15098894

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACJOAZ725 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9 In Stock
  2. Plus
  3. ACLKVF847 route compound structure diagram
    ACLKVF847133427-08-4 In Stock
  4. Then
  5. ACJOAZ725 route product structure diagram
    ACJOAZ725133427-07-3 In Stock
Inquiry

2. ACJOAZ725 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACXWBF904 route compound structure diagram
    ACXWBF90414667-47-1 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACJOAZ725 route product structure diagram
    ACJOAZ725133427-07-3 In Stock
Inquiry

Comments (0)